false
OasisLMS
Catalog
Self-Study Resources
What is Biomarker Testing for Advanced Lung Cancer ...
What is Biomarker Testing for Advanced Lung Cancer and Why is it Important? - Video
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this webinar, Dr. Bruce Johnson discusses the importance of biomarker testing for advanced lung cancer. He focuses on various mutations and rearrangements, such as EGFR, ALK, ROS1, BRAF, and PD-L1, and how targeted therapies have transformed patient care. Dr. Johnson highlights the significance of knowing the specific mutation and the importance of testing for these biomarkers to determine the most appropriate treatment. He presents case studies of patients who have shown positive responses to targeted therapies and immunotherapy, emphasizing the prolonged survival and improved quality of life for these individuals. Dr. Johnson also addresses the low testing rates for biomarkers, stressing the need for broader molecular testing and faster turnaround times for results. He concludes that the field of biomarker testing is continuously evolving, with new agents gaining approval and expanding treatment options for patients with advanced lung cancer.
Keywords
biomarker testing
advanced lung cancer
mutations
targeted therapies
patient care
specific mutation
immunotherapy
prolonged survival
treatment options
×
Please select your language
1
English